Chief Sales Officer "Mark" — Follow His Story
Mark had changed the way he thought about field readiness. Completing training and passing certification were still important, but he now understood that neither necessarily proved a representative could execute an effective HCP conversation. Readiness had to include the ability to apply knowledge, demonstrate the right behaviors, and adapt when the conversation became difficult.
That distinction became much more important when his organization began preparing for a major launch. New clinical data had to be understood. Messaging had to change. Representatives needed to recognize new patient opportunities, navigate anticipated objections, and communicate the value of the product accurately and compliantly. The launch plan was comprehensive, the training calendar was full, and leadership was closely tracking progress.
As launch approached, Mark's dashboards looked reassuring. Training completion was high, assessments were being passed, and certification was on schedule. Yet he found himself returning to the same question he had asked about field readiness: Did all of that activity actually mean the field was ready to perform?
This time, the stakes were even higher. With a launch date approaching, Mark couldn't afford to discover the answer after representatives were already in front of customers.
Pharma Launches Create a Different Kind of Skill Challenge
Product launches, new indications, and major messaging changes place enormous demands on pharmaceutical field organizations. Teams aren't simply learning new information. They are being asked to change how they perform, often within a compressed period of time.
A representative may need to understand new clinical evidence while simultaneously learning how that evidence changes the customer conversation. Managers need to reinforce new behaviors while continuing to support existing business priorities. Learning teams need to prepare hundreds or thousands of employees while scientific, legal, regulatory, marketing, and commercial stakeholders continue refining the information the field will use.
Traditional launch plans are very good at managing the distribution of knowledge. Organizations can track whether employees attended training, consumed required content, passed assessments, and completed certification. But those metrics primarily tell leaders whether the organization has successfully delivered the launch curriculum.
Mark needed to know something different. He needed to know whether the organization had successfully built the capabilities required for launch execution.
The Most Important Launch Metric May Be the Hardest One to See
As Mark met with his commercial and learning leaders, he asked them to define what a "launch-ready" representative should actually be able to do.
The conversation quickly moved beyond product knowledge. A launch-ready representative needed to interpret the clinical evidence, communicate it clearly, identify the right customer opportunity, navigate predictable objections, respond to unexpected questions, execute the organization's selling model, and remain within appropriate compliance boundaries.
Those expectations gave Mark a much clearer definition of readiness. They also exposed a measurement gap.
His organization could easily answer:
- What percentage of the field completed launch training?
- What percentage passed the knowledge assessment?
- How many representatives completed certification?
- Which regions were on schedule?
- How much training had been delivered?
- Which representatives could confidently execute the new HCP conversation?
- Which skills were strongest across the field?
- Where were representatives consistently struggling?
- Which objections were creating the greatest difficulty?
- Which teams needed additional practice before launch?
- Where should managers focus their coaching?
- Was field capability improving quickly enough to meet the launch date?
- What does the field need to know?
- What does the field need to be able to do?
- What does good execution look like?
- How will representatives practice it?
- How will we know when they can do it consistently?
- Define: Identify the capabilities required for successful launch execution.
- Learn: Build the scientific, product, customer, and business knowledge supporting those capabilities.
- Practice: Apply that knowledge in realistic HCP conversations before entering the field.
- Measure: Evaluate proficiency and identify skill gaps across individuals, teams, and the organization.
- Coach: Use performance insights to focus manager development where it can have the greatest impact.
- Reinforce: Continue practicing and developing capabilities as field experience and market conditions evolve.
But the questions Mark cared about most were harder to answer:
Those questions weren't really about training activity. They were about organizational capability, and Mark realized his organization often received the best evidence about that capability only after launch.
Pharma Often Measures Launch Readiness After the Launch
Once a product or indication reaches the field, pharmaceutical organizations begin receiving a new stream of information. Managers observe representatives. Customer conversations generate feedback. Commercial performance begins to emerge. Market response becomes clearer. Leaders start identifying where messaging is landing and where field execution is inconsistent.
That information is incredibly valuable, but it creates a fundamental problem: the organization is learning about readiness after readiness was already required.
If representatives struggle with a particular objection, the organization can respond with reinforcement. If managers identify inconsistent execution, additional coaching can be provided. If a skill gap emerges across the field, new training can be developed.
Those responses improve performance over time, but Mark saw an opportunity to move that learning cycle earlier. What if the organization could identify those same gaps during preparation rather than waiting for actual HCP conversations to expose them?
Launch readiness could become something the organization measured before launch, not something it inferred afterward.
Define the Capabilities Before Building the Training
Mark's team began changing the sequence of their launch planning. Instead of starting exclusively with the information representatives needed to receive, they started by defining the capabilities representatives needed to demonstrate.
That required the commercial, learning, and field leadership teams to get specific. If representatives were expected to communicate a new study, what did effective execution actually look like? If the strategy depended on changing physician perceptions, what conversational skills would make that possible? If certain objections were expected, what behaviors should representatives demonstrate when they encountered them?
The resulting launch plan began with a different set of questions:
Training remained part of the answer, but it was no longer the entire answer. The organization was designing backward from performance.
Practice Turns Launch Preparation Into Readiness Data
Once the required capabilities were defined, Mark saw why practice had become so important.
A knowledge assessment could tell him whether a representative understood the new clinical study. A realistic simulation could show whether that representative could use the information effectively when an HCP challenged the study, questioned its relevance, or introduced an unexpected concern.
The difference was significant because practice created something the organization previously lacked: performance data before field execution.
In a program supporting an expanded Botox Account Specialist team, approximately 200 representatives used AI-powered roleplay to practice conversations around a new chronic migraine study. Learners averaged three simulation attempts, accumulated approximately 33 minutes of focused conversational practice, and demonstrated a 5% improvement in targeted skills within one week. The program also incorporated Fact Checker capabilities to validate responses against study information and help reinforce accurate, compliant execution.
For Mark, the value wasn't simply that representatives could practice more often. Their practice created visibility into how the field was progressing toward proficiency.
Instead of waiting for managers to discover execution gaps after launch, learning and commercial leaders could see where representatives were struggling during preparation. Managers could focus coaching on specific needs. Additional practice could be assigned where necessary. Launch support could become more targeted because the organization had evidence about capability rather than assumptions based primarily on completion.
Readiness Should Be a Progression, Not a Pass/Fail Event
Traditional certification can unintentionally make readiness feel binary. A representative either passes or doesn't. Once the required score is achieved, the individual moves forward.
Skill development rarely works that way. Capability develops through repetition, feedback, adjustment, and continued application.
Mark began thinking about launch readiness as a progression. A representative might understand the new clinical information but initially struggle to communicate it naturally. Another might deliver the messaging effectively but have difficulty responding when the HCP becomes resistant. Someone else might handle objections well but miss opportunities to ask the right questions.
Those aren't necessarily certification failures. They are development signals.
AI-powered progressive roleplay provides an example of what this model can look like. MannKind used scenarios with increasing levels of difficulty, allowing representatives to progress from more amenable physician interactions toward resistant conversations requiring trust rebuilding. Learners could repeat scenarios, receive standardized behavioral scoring, and demonstrate improvement over multiple attempts rather than relying on a single practice event.
This gave Mark another way to think about readiness. The objective wasn't simply to determine whether someone had crossed a minimum threshold. It was to understand where they were in the development process and whether they were progressing quickly enough for the business need.
Managers Become More Valuable When They Know Where to Coach
Mark also noticed that better readiness data changed the role of frontline managers.
Managers had always been critical to launch execution, but their coaching often depended on what they personally observed. That meant identifying skill gaps required time in the field, and coaching priorities could vary significantly from manager to manager.
Practice data gave managers a starting point. Instead of spending coaching time trying to determine where a representative needed help, they could use performance insights to focus directly on the behaviors creating difficulty.
A manager might see that a representative understood the clinical information but consistently struggled with a particular objection. Another representative might be technically accurate but need to improve questioning or listening behaviors. A third might demonstrate strong performance and be ready for a more difficult scenario.
This doesn't replace the manager. It makes the manager's limited coaching time more targeted. Practice, measurement, and coaching begin working together rather than functioning as separate parts of the launch plan.
Mark Started Measuring Something Different
As launch approached, Mark still reviewed completion rates and certification results. Those measures remained necessary. But they were no longer the only indicators he wanted to see.
He also wanted visibility into practice participation, proficiency across critical behaviors, progression across attempts, common skill gaps, areas requiring manager intervention, and readiness patterns across teams and regions.
The shift changed the launch conversation. Instead of asking only, "Are we on schedule with training?", Mark could ask, "Is field capability developing at the speed the launch requires?"
That question moved learning much closer to the business. A launch wasn't successful because training happened on time. It was successful when the organization could translate new science, strategy, and messaging into consistent field execution quickly enough to capitalize on the market opportunity.
From Speed to Training to Speed to Capability
Pharmaceutical organizations have spent years becoming faster and more sophisticated at deploying learning. Digital platforms, virtual training, modular content, and modern learning technologies have made it possible to distribute information across large field organizations quickly.
But Mark realized that speed to training isn't the same as speed to capability.
A stronger launch-readiness model connects the entire development journey:
This gives leaders something they rarely have during a traditional launch: a view into whether capability is actually developing before commercial performance becomes the final indicator.
Key Takeaways
Pharmaceutical launch readiness requires more than delivering training and completing certification on schedule. Launches require field teams to develop new capabilities quickly, apply complex scientific information in unpredictable customer conversations, and execute consistently when the commercial opportunity is at its most time-sensitive.
Organizations can improve launch readiness by defining the required capabilities before designing the learning experience, creating opportunities for repeated application, measuring skill progression during preparation, and using those insights to guide manager coaching and reinforcement.
For Mark, the question had evolved again. It was no longer simply whether his field was trained or even whether individual representatives were ready. He wanted to know how quickly the entire organization could build a new capability when the business needed it.
That question would lead him directly into the next challenge: AI could dramatically increase access to practice, but in a highly regulated pharmaceutical environment, not all AI practice carries the same level of accuracy, relevance, or risk.
Next in Mark's story: AI Roleplay Is Easy. Building Pharma-Ready AI Practice Is Hard.
.png)
